Covered recipient · General Payments record
JESSICA A LAUDERDALE
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2023
$1,775.47
- Reported across 123 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $188.53 | 12 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $35.07 | 2 |
| Novo Nordisk AS | $33.60 | 2 |
| PFIZER INC. | $30.30 | 2 |
| Astellas Pharma US Inc | $22.28 | 1 |
| Nevro Corp. | $17.60 | 1 |
| ABBVIE INC. | $16.39 | 1 |
| Lilly USA, LLC | $14.29 | 1 |
| Amgen Inc. | $14.00 | 1 |
| Sumitomo Pharma America, Inc. | $5.00 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (12)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $16.39 | 06/29/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997731455 | CMS |
| Amgen Inc. | $14.00 | 05/23/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1019965047 | CMS |
| Astellas Pharma US Inc | $22.28 | 06/26/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1034225749 | CMS |
| E.R. Squibb & Sons, L.L.C. | $20.59 | 03/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1016059849 | CMS |
| E.R. Squibb & Sons, L.L.C. | $14.48 | 06/23/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1016059897 | CMS |
| Lilly USA, LLC | $14.29 | 01/30/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1031531597 | CMS |
| Nevro Corp. | $17.60 | 06/30/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1051685351 | CMS |
| Novo Nordisk Inc | $17.53 | 02/17/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1001768565 | CMS |
| Novo Nordisk Inc | $16.07 | 05/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1001768555 | CMS |
| PFIZER INC. | $15.15 | 02/08/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1049547677 | CMS |
| PFIZER INC. | $15.15 | 05/12/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1049301705 | CMS |
| Sumitomo Pharma America, Inc. | $5.00 | 03/01/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1030869353 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.